Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25939392.
- Also identified by DOI 10.7554/eLife.06847 and PMC identifier 4443697.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The Science Translational Medicine in 2011 (Sirota et al., 2011). The key experiments being replicated include Figure 4C and D and Supplemental Figure 1. In these figures, Sirota and colleagues. tested a proof of concept experiment validating their prediction that cimetidine, a histamine-2 (H2) receptor agonist commonly used to treat peptic ulcers (Kubecova et al., 2011), would be effective against lung adenocarcinoma (Figure 4C and D). As a control they also tested the effects of cimetidine against renal carcinoma, for which it was not predicted to be efficacious (Supplemental Figure 1). The Reproducibility Project: Cancer Biology is a collaboration between the eLife.
Medical subject headings
- Adenocarcinoma
- Carcinoma, Renal Cell
- Cimetidine
- Histamine H2 Antagonists
- Kidney Neoplasms
- Lung Neoplasms